SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.400+1.7%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bobbseytwins2001 who wrote (1135)8/15/2025 3:22:25 PM
From: Olecranon2 Recommendations

Recommended By
CCS648
Stanley Lake 92

   of 1216
 
PSS may be able to keep cash flow positive with his checking account (one of the reasons that I’ve generally felt that most of the risk to IBRX is off the table). But in all the years that I’ve been in IBRX, every injection of cash that I can think of has led to shareholder dilution with simutaneous reinforcement of PSS’s own position. I’m feeling PSS’s wealth but not his generosity.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News